The chemical class known as Vmn2r20 activators encompasses a diverse group of compounds that can engage in the modulation of the Vmn2r20 receptor, a member of the vomeronasal type-2 receptor family. These activators are characterized by their ability to influence the signaling pathways within the olfactory system, particularly those associated with the vomeronasal organ (VNO), a sensory organ responsible for detecting pheromones and other chemical signals. The chemicals in this class act through various mechanisms to enhance or sustain the signaling cascades that can lead to the activation of Vmn2r20, without directly binding to the receptor itself. Their actions include the modulation of intracellular second messengers, alteration of enzyme activity that is involved in signal transduction, and changes in ion concentrations within cells, all of which are crucial for the proper functioning of G-protein coupled receptors (GPCRs) like Vmn2r20.
The efficacy of Vmn2r20 activators is rooted in their ability to amplify the signaling processes that are integral to the operation of Vmn2r20. By increasing the levels of secondary messengers or by maintaining their activity within the cell, these chemicals can enhance the signal that is ultimately relayed by Vmn2r20. Additional methods of action include altering the balance of protein activation or inhibition that governs the signal transduction pathways, as well as modulating the availability of ions that serve as signaling molecules. Through these various avenues, Vmn2r20 activators can ensure that the intracellular environment is conducive to the propagation of signals that originate from the interaction of ligands with the Vmn2r20 receptor, thereby enabling the receptor to participate more effectively in the complex communication network of the olfactory system.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents cAMP degradation, thereby sustaining signaling that could possibly activate Vmn2r20-mediated pathways. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin can inhibit Gαi proteins, which might lead to altered signaling dynamics that could possibly activate Vmn2r20. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
NaF is a G protein activator that can stimulate GPCR signaling, potentially affecting intracellular signaling events that could possibly activate Vmn2r20. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 increases intracellular calcium levels, which is a crucial secondary messenger in GPCR signaling, and could possibly activate Vmn2r20-mediated responses. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is an inhibitor of the endoplasmic reticulum Ca2+-ATPase, leading to increased cytosolic calcium levels and could possibly activate Vmn2r20 signaling. | ||||||
BAPTA/AM | 126150-97-8 | sc-202488 sc-202488A | 25 mg 100 mg | $138.00 $458.00 | 61 | |
BAPTA-AM can modulate intracellular calcium levels, thus potentially influencing signaling pathways that could possibly activate Vmn2r20. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog which activates protein kinase C (PKC), a key player in GPCR signaling that could possibly modulate Vmn2r20-associated pathways. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
cAMP is a secondary messenger directly involved in GPCR signaling, which could enhance the signal transduction processes that could possibly activate Vmn2r20. | ||||||